Biotech

All Articles

Biogen, UCB report period 3 lupus win after neglecting earlier test

.Biogen and also UCB's gamble on advancing right into stage 3 astride a failed research study seeks ...

Aptadir wishes brand-new RNA preventions can turn around complicated cancers cells

.Italian biotech Aptadir Therapies has launched along with the assurance that its pipe of preclinica...

Wave surfs DMD success to regulatory authorities' doors, sending out stock up

.Wave Lifestyle Sciences has met its own goal in a Duchenne muscular dystrophy (DMD) research, placi...

Sanofi plucks brand new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma crease...

Achilles splashes tissue therapy course, bandages for cutbacks after overlooking 'commercial practicality' goals

.Achilles Therapies has actually wrecked its own strategy. The English biotech is actually knocking ...

Aligos trumpets phase 2 MASH succeed, slashing liver fat up to 46%

.Aligos Therapeutics is actually proclaiming a midstage succeed in metabolic-dysfunction linked stea...

Basilea credit ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's job cultivating new antifungals has acquired a significant boost from the U...

Capricor markets Europe legal rights to late-stage DMD treatment for $35M

.Having already scooped up the united state rights to Capricor Therapies' late-stage Duchenne muscle...

FDA junks adcomm for Applied's unusual illness medication

.After pushing the selection date for Applied Rehabs' metabolic disorder medicine govorestat, the FD...

Novo inks $600M NanoVation offer to examine hereditary medicines ex-liver

.Novo Nordisk is continuing its own push into genetic medications, accepting pay NanoVation Therapie...